Quercitin
Also known as: Quercetin, Sophoretin, Meletin, 3,3′,4′,5,7-pentahydroxyflavone
Overview
Quercetin is a flavonoid, a type of plant-derived polyphenol, found in various fruits, vegetables, and beverages like tea and red wine. Known for its antioxidant and anti-inflammatory properties, it's commonly used as a dietary supplement. It is often explored for its potential cardioprotective, antiviral, and immune-supporting effects. Quercetin is characterized by its poor water solubility and limited oral bioavailability, which has led to the development of various formulations aimed at enhancing its absorption. Research on quercetin is fairly mature, with numerous preclinical and clinical studies, including randomized controlled trials and meta-analyses, investigating its effects on various health outcomes. The quality of evidence varies depending on the specific application, with stronger support for its antioxidant and anti-inflammatory effects and more moderate evidence for cardiovascular and immune-related benefits.
Benefits
Quercetin supplementation has demonstrated anti-inflammatory and antioxidant effects. Meta-analyses suggest that daily doses of 500-1000 mg can reduce C-reactive protein (CRP) levels by approximately 0.5 mg/L in adults with chronic conditions. Additionally, a systematic review and meta-analysis indicated that quercetin supplementation can reduce systolic blood pressure by 3.0 mmHg and diastolic blood pressure by 2.0 mmHg in hypertensive individuals. Some studies suggest potential immune modulation, with possible reductions in upper respiratory tract infection incidence or duration, although results are inconsistent. Limited evidence also points to modest improvements in exercise endurance and recovery. Benefits are generally more pronounced in individuals with existing inflammation or hypertension.
How it works
Quercetin functions primarily as an antioxidant by directly scavenging reactive oxygen species (ROS) and boosting the production of endogenous antioxidant enzymes like superoxide dismutase and catalase. It also inhibits pro-inflammatory pathways, including NF-κB and MAPK signaling, which reduces the production of inflammatory mediators. Furthermore, quercetin modulates immune cell function, endothelial function, and vascular smooth muscle tone, contributing to its anti-inflammatory and vasodilatory effects. At the molecular level, it inhibits enzymes like lipoxygenase and cyclooxygenase, which are involved in inflammation, and modulates cytokine production, such as TNF-α and IL-6. It also influences nitric oxide bioavailability, enhancing endothelial function.
Side effects
Quercetin is generally considered safe at supplemental doses up to 1000 mg/day, though long-term safety data are limited. Common side effects include mild gastrointestinal discomfort, such as nausea or upset stomach. Less common side effects may include headache and tingling sensations. Rare side effects include allergic reactions and potential nephrotoxicity at very high doses. Quercetin may interact with certain drugs by inhibiting CYP3A4 and P-glycoprotein, potentially affecting the metabolism of medications like cyclosporine, warfarin, and some chemotherapeutics. Caution is advised for individuals on anticoagulants or immunosuppressants. Due to limited data, use during pregnancy and lactation should be approached with caution. Elderly individuals may benefit from its antioxidant effects but should be monitored for potential drug interactions.
Dosage
The minimum effective dose of quercetin is approximately 500 mg/day for measurable anti-inflammatory and blood pressure effects. Optimal dosage ranges are typically between 500-1000 mg/day, divided into multiple doses to improve absorption and minimize gastrointestinal side effects. Doses up to 1000 mg/day are generally considered safe, but exceeding this amount may not have sufficient safety data. It is recommended to take quercetin with meals, especially those containing dietary fats, to enhance absorption. Using quercetin glycosides or enhanced bioavailability formulations, such as quercetin phytosome, can also improve efficacy. Co-ingestion with vitamin C may synergize antioxidant effects and improve quercetin stability.
FAQs
Is quercetin safe for daily use?
Yes, quercetin is generally safe at doses up to 1000 mg/day for up to 12 weeks, with mild side effects reported in some individuals.
When should I take quercetin?
It is best to take quercetin with meals, preferably those containing fat, to improve its absorption and bioavailability.
How soon will I see benefits from quercetin?
Noticeable effects on inflammation and blood pressure typically appear after 4-12 weeks of consistent supplementation.
Does quercetin boost immunity?
Evidence is mixed; it may modestly reduce respiratory infection risk but is not a substitute for vaccines or medical treatment.
Can I take quercetin with medications?
Consult a healthcare provider due to potential interactions, especially with blood thinners and immunosuppressants.
Research Sources
- – This review article summarizes quercetin's antioxidant, anti-inflammatory, and cardiovascular effects. It highlights mechanisms and clinical trial data showing modest blood pressure and inflammation reductions, providing a comprehensive overview of quercetin's therapeutic potential. The review offers a moderate evidence synthesis, making it a valuable resource for understanding quercetin's multifaceted applications.
- – This randomized controlled trial (RCT) involving 93 overweight adults found that a daily dose of 150 mg of quercetin for 6 weeks significantly reduced systolic blood pressure by 4.6 mmHg and lowered oxidized LDL levels. While the study demonstrated promising results, its limitations include a moderate sample size and a relatively short duration, suggesting the need for further research to confirm these findings.
- https://www.ahajournals.org/doi/10.1161/JAHA.116.003735 – This meta-analysis of 7 RCTs, with a total of 587 participants, examined the effects of quercetin supplementation at doses ranging from 150-1000 mg/day over 4-12 weeks. The analysis revealed a systolic blood pressure reduction of 3.04 mmHg and a diastolic blood pressure reduction of 2.63 mmHg in hypertensive subjects. The study acknowledges potential heterogeneity in populations and doses, as well as the possibility of publication bias, highlighting areas for further investigation.
